Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine long-term safety in adolescents
NCT00982020Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of olanzapine in bipolar I disorder, schizophrenia, sponsored by Eli Lilly and Company. Started Sep 2009; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar I disorderschizophrenia
Beyond the preview
Go deeper on NCT00982020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982020.